1. Pectin co-functionalized dual layered solid lipid nanoparticle made by soluble curcumin for the targeted potential treatment of colorectal cancer
- Author
-
Fazil Ahmad, Ali Alqahtani, J. Muthu Mohamed, V. Krishnaraju, and K. Kalpana
- Subjects
Male ,food.ingredient ,Curcumin ,Polymers and Plastics ,Pectin ,Biological Availability ,Antineoplastic Agents ,02 engineering and technology ,010402 general chemistry ,01 natural sciences ,Flow cytometry ,chemistry.chemical_compound ,food ,Pharmacokinetics ,Western blot ,Cell Line, Tumor ,Solid lipid nanoparticle ,Materials Chemistry ,medicine ,Animals ,Humans ,Rats, Wistar ,Cytotoxicity ,Zebrafish ,Drug Carriers ,medicine.diagnostic_test ,Cell Death ,Organic Chemistry ,021001 nanoscience & nanotechnology ,Lipids ,0104 chemical sciences ,Bioavailability ,Rats ,Molecular Docking Simulation ,Drug Liberation ,Milk ,chemistry ,Nanoparticles ,Pectins ,0210 nano-technology ,Colorectal Neoplasms ,Nuclear chemistry - Abstract
The investigation is to increase the cytotoxicity of soluble curcumin (SC) by loading it onto pectin and skimmed milk powder (SMP) dual layered solid lipid nanoparticles (DL-SLN). The DL-SLN exhibited significantly higher encapsulation efficiency (83.94 ± 6.16), better stability (90 days), and sustained the drug release in different gastro intestional (GI) environments upto 72 h. Molecular docking revealed that the Vander Waals (57420.669 Kcal-mol-1) and electrostatic (-197.533) bonds were involved in the DL-SLN complex formation. The in vivo toxicity of DL-SLN was performed by the zebrafish model, the cell cycle arrest at G2/M phase (64.34 %) by flow cytometry, and western blot investigation was recognized molecular level cell death using SW480 cells. Pharmacokinetic (PK) evaluation (Cmax-5.78 ± 3.26 μg/mL; Tmax-24 h) and organ distribution studies confirmed that the co-functionalized pectin based SLN could efficiently improve the oral bioavailability (up to 72 h) of curcumin (CMN) on colon-targeted release.
- Published
- 2020